INS and type 1 diabetes mellitus: More recently, a panelist expert opinion has recommended in favour of the adjunctive use of GLP‐1RAs to insulin pump (the most effective treatment in T1D) as emerging evidence supports the combination for ameliorating glucose control, reducing overall daily insulin requirement without increasing risks related to insulin depletion, and providing effective weight control or sustained weight loss [109].